Publications

Contact us

Talk to Someone or Make an Appointment

This bibliography features recent publications by Swedish Cancer Institute members and affiliated physicians (noted in bold) in 2015, 2016 and 2017.

Breast Cancer
Gastroenterological Cancer
Genitourinary Cancer
Gene Sequencing/Personalized Medicine
Gynecologic Cancer
Head and Neck Cancer
Hematologic Malignancies
Neurological Cancer
Practice Management
Supportive Care
Thoracic Cancer
Other

Breast Cancer

Albain KS, Unger JM, Livingston RB, Crew KD, Wilczynski SP, Salomon CG, Smith BL, Wong L, Campbell DL, Einspahr DE, Anderson GL, Hershman D, Goodman GE, Brown PH, Meyskens FL, Potkul RK.  Randomized Trial of Medroxyprogesterone Acetate for Prevention of Endometrial Pathology from Adjuvant Tamoxifen for Breast Cancer: SWOG S9630.  American Society of Clinical Oncology, Chicago, Illinois, Jun 2016.

Andersen MR, Thorpe J, Buist DS, Beatty JD, Watabayashi K, Hanson N, Resta R, et al. Cancer risk awareness and concern among women with a family history of breast or ovarian cancer. Behav Med. 2016;42(1):18-28. doi: 10.1080/08964289.2014.947234. [Epub 2014 Nov 3] [PubMed]

Calip GS, Malmgren JA, Lee W-J, Schwartz SM, Kaplan HG. Myelodysplastic syndrome and acute myeloid leukemia following adjuvant chemotherapy with and without granulocyte colony-stimulating factors for breast cancer. Breast Can Res Treat. 2015 Nov;154(1):133-43. doi: 10.1007/s10549-015-3590-1. [Epub 2015 Oct 8] [PubMed]

DeMichele A, Yee D, Berry DA, Albain KS, Benz CC, Boughey J, Buxton M, Chia SK, Chien AJ, Chui SY, Clark A, Edmiston K, Elias DA, Forero-Torres A, Haddad TC, Haley B, Haluska P, Hylton NM, Isaacs C, Kaplan H, et al. The Neoadjuvant Model is Still the Future for Drug Development in Breast Cancer. Clin Ca Res. 2015 Jul 1;21(13):2911-5. doi: 10.1158/1078-0432.CCR-14-1760. [Epub 2015 Feb 24] [PubMed]

Jung S, Wang M, Anderson K, Baglietto L, Bergkvist L, Bernstein L, van den Brandt PA, Brinton L, Buring JE, Heather Eliassen A, Falk R, Gapstur SM, Giles GG, Goodman G, et al. Alcohol consumption and breast cancer risk for estrogen receptor status: in a pooled analysis of 20 studies. Int J Epidemiol. 2016 Jun;45(3):916-28. doi: 10.1093/ije/dyv156. [Epub 2015 Aug 28] [PubMed]

Bland KA, Kirkham AA, Bovard J, Lloyd M, Shenkier T, Davis M, Zucker D, Claydon VE, Gelmon K, McKenzie DC, Campbell KA. Chemotherapy-periodized” exercise for women with breast cancer: Feasibility of a novel exercise prescription to account for increases in self-reported fatigue. Canadian Society for Exercise Physiology Annual Meeting, October 2017, Winnipeg, MB.

Bland KA, Kirkham AA, Bovard J, Lloyd M, Shenkier T, Davis MK, Zucker D, Gelmon KA, McKenzie DC, Claydon VE, Campbell KA.  Influence of supervised exercise during versus after taxane chemotherapy for breast cancer on quality of life. Abstract, 4th Canadian Cancer Research Conference, Nov 4-7, 2017, Vancouver Convention Centre, Vancouver, British Columbia.

Kaplan H, Malmgren J, Atwood M, Calip G. Effect of Treatment and Mammography Detection on Breast Cancer Survival Over Time: 1990-2007. Cancer. 2015 Aug 1;121(15):2553-61. doi: 10.1002/cncr.29371. [Epub 2015 Apr 14] [PubMed]

Leger R, Jain S, Nester T, Kaplan, H. Drug-induced Immune Hemolytic Anemia Due to Anti-Carboplatin Plus the First Example of Anti-Paclitaxel. Transfusion. 2015 Dec;55(12):2949-54. doi: 10.1111/trf.13255. [Epub 2015 Aug 11] [PubMed]

Lloyd M, Bland KA, Kirkham AA, Bovard J, Shenkier T, Davis M, Zucker D, Gelmon K, McKenzie D, Victoria C, Campbell K. The influence of exercise training on indices of autonomic nervous system function among women undergoing paclitaxel chemotherapy for breast cancer. Abstract and Poster, Global Cardio-Oncology Summit, Sept 29-30, 2016, Vancouver, BC.

MacDonald LR, Hippe DS, Bender LC, Cotter EW, Voria PR, Hallam PS, Wang CL, Haseley DR, Kelly MM, Parikh JR, Beatty JD, Rogers JV. Positron Emission Mammography Image Interpretation for Reduced Image Count Levels. J Nucl Med. 2016 Mar;57(3):348-54. doi: 10.2967/jnumed.115.165787. [Epub 2015 Dec 3] [PubMed]

Potkul RK, Unger JM, Livingston RB, Crew KD, Wilczynski SP, Salomon CG, Smith BL, Wong L, Campbell DL, Einspahr DE, Anderson GL, Hershman D, Goodman GE, Brown PH, Meyskens FL, Albain KS.  Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630.  npi Breast Cancer. 2016 Aug 10;2:16024. doi: 10.1038/npjbcancer.2016.24. [eCollection 2016] [PubMed]

Vermeulen S, Giap H, Cotrutz C, Douglas R, Morris A. Stereotactic Body Radiotherapy: A Practical Guide for the Delivery of Accelerated Partial Breast Irradiation. In: Stereotactic Body Radiotherapy London: Springer-Verlag. 2015;293-314.

Gastroenterological Cancer

Baer C, Menon R, Bastawrous S, Bastawrous A. “Emergency Presentations of Colorectal Emergencies” in Advances in Colorectal Neoplasia in Surg Clin North Am. 2017 Jun;97(3):529-545. doi: 10.1016/j.suc.2017.01.004. [PubMed]

Bastawrous A. Ischemic Bowel Disease. In: BMJ Point of Care. 2015.

Bastawrous A, Hawkins M, Kratz R, et al. Results From a Novel Modification to the Ligation Intersphincteric Fistula Tract. Am J Surg. 2015 May;209(5):793-8; discussion 798. doi: 10.1016/j.amjsurg.2015.01.002. [Epub 2015 Feb 16] [PubMed]

Bastawrous S, McKeown E, Bastawrous A. Adult Ileocolic Intussusception Presenting as Small Bowel Metastatic Melanoma. Radiol Case Rep. 2015 Oct 24;10(4):46-8. doi: 10.1016/j.radcr.2015.08.007. [eCollection 2015] [PubMed]

Cleary R, Kassir A, Johnson C, Bastawrous AL, et al, Intracorporeal versus Extracorporeal Anastomosis for Minimally Invasive Right Colectomy: A Multi-Center Propensity Score-Matched Comparison of Outcomes, Annals of Surgery. 2017

Cologne K, Bastawrous A. How to achieve cecal intubation in patients with angulated and redundant colons? Seminars in Colon and Rectal Surgery 28 (2017) 4–7. [Science Direct]

Colorectal Writing Group for Surgical Care and Outcomes Assessment Program–Comparative Effectiveness Research Translation Network (SCOAP-CERTAIN) Collaborative, Nelson DW, Simianu VV, Bastawrous AL, Billingham RP, Fichera A, Florence MG, et al. Thromboembolic Complications and Prophylaxis Patterns in Colorectal Surgery. JAMA Surg. 2015 Aug;150(8):712-20. doi: 10.1001/jamasurg.2015.1057. [PubMed]

Ehlers AP, Simianu VV, Bastawrous AL, et al. Alvimopan Use, Outcomes, and Costs: A Report from the Surgical Care and Outcomes Assessment Program Comparative Effectiveness Research Translation Network Collaborative. J Am Coll Surg. 2016 May;222(5):870-7. doi: 10.1016/j.jamcollsurg.2016.01.051. [Epub 2016 Feb 5] [PubMed]

Kinon MD, Scoco A, Farinhas JM, Kobets A, Weidenheim KM, Yassari R, Lasala PA, Graber JJ. Glioblastoma multiforme presenting with an open ring pattern of enhancement on MR imaging. Surg Neurol Int. 2017 Jun 13;8:106. doi: 10.4103/sni.sni_35_17. [eCollection 2017] [PubMed]

Lee J, Bastawrous A. Proctalgia Fugax, Levator Syndrome and Pelvic Pain, In: Fundamentals of Anorectal Surgery ,3rd edition: (in press). 2017

Hakkarainen, TW, Steele, SR, Bastawrous, A, et al. Non-Steroidal Anti-Inflammatory Drugs and the Risk of Anastomotic Failure:  A Report from Washington State’s Surgical Care and Outcomes Assessment Program (SCOAP). JAMA Surg. 2015 Mar 1;150(3):223-8. doi: 10.1001/jamasurg.2014.2239. [PubMed]

Makarawo T, Bastawrous S, Bastawrous A. Splenic Flexure Mobilization as Treatment for Chronic Partial Large Bowel Obstruction Following Gastric Bypass; A Case Report (submitted) 2017.

McKeown E, Bastawrous AL. Robotic Training. In: Robotic Approaches to Colorectal Surgery. New York, NY; Springer. 2015.

Rashidi L, Neighorn C and Bastaworus A. Outcome Comparisons Between High-Volume Robotic and Laparoscopic Surgeons in a Large Healthcare System, Am J Surg. 2017 May;213(5):901-905. doi: 10.1016/j.amjsurg.2017.03.034. [Epub 2017 Apr 6] [PubMed]

Simianu VV, Fichera A, Bastawrous AL, Davidson GH, Florence MG, et al. Number of Diverticulitis Episodes Before Resection and Factors Associated With Earlier Interventions. JAMA Surg. 2016 Feb 10; doi: 10.1001/jamasurg.2015.5478. [PubMed]

Simianu VV, Sinanan MN, Bastawrous AL, et al. The Impact of Delaying Elective Resection of Diverticulitis on Laparoscopic Conversion Rate. Am J Surg. 2015 May;209(5):913-8; discussion 918-9. doi: 10.1016/j.amjsurg.2014.12.027. [Epub 2015 Feb 25] [PubMed]

Steele SR, Varma MG, Prichard D, Bharucha AE, Vogler SA, Erdogan A, Rao SS, Lowry AC, Lange EO, Hall GM, Bleier JI, Senagore AJ, Maykel J, Chan SY, Paquette IM, Audett MC, Bastawrous A, Umamaheswaran P, Fleshman JW, Caton G, O'Brien BS, Nelson JM, Steiner A, Garely A, Noor N, Desrosiers L, Kelley R, Jacobson NS. The evolution of evaluation and management of urinary or fecal incontinence and pelvic organ prolapse. Curr Prob Surg. 2015 Mar;52(3):92-136. doi: 10.1067/j.cpsurg.2015.02.001. [Epub 2015 Feb 7] [PubMed]

Subramaniam SGoodman GE, Boatman B,  Smith AWIriarte D, Gold PJ. A phase Ib study of AUY922 and cetuximab in patients with KRAS wild-type (WT) metastatic colorectal cancer (mCRC). J Clin Oncol. 2015:33 (suppl; abstr 3540). Poster Presentation.

Thornblade LW, Varghese TK, Shi X, Bastawrous AL ,et al. Preoperative Immunonutrition and Elective Colorectal Resection Outcomes. Dis Colon Rectum. 2017:60(1):68-75. PMID: 27926559 [PubMed]

Zhang M, Wang Z, Obazee O, Jia J, Childs EJ, Hoskins J, Figlioli G, Mocci E, Collins I, Chung CC, Hautman C, Arslan AA, Beane-Freeman L, Bracci PM, Buring J, Duell EJ, Gallinger S, Giles GG, Goodman GE, et al. Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21. Oncotarget. 2016 Oct 11;7(41):66328-66343. doi: 10.18632/oncotarget.11041. [PubMed]

Genitourinary Cancer

Allen NE, Travis RC, Appleby PN, Albanes D, Barnett MJ, Black A, Bueno-de-Mesquita HB, Deschasaux M, Galan P, Goodman GE, et al. Selenium and Prostate Cancer: Analysis of Individual Participant Data from Fifteen Prospective Studies. J Natl Cancer Inst. 2016 Jul 6;108(11). pii: djw153. doi: 10.1093/jnci/djw153. Print 2016 Nov. [PubMed]

Huber RM, Lucas JM, Gomez-Sarosi LA, Coleman I, Zhao S, et al. DNA damage induces GDNF secretion in the tumor microenvironment with paracrine effects promoting prostate cancer treatment resistance. Oncotarget. 2015;6(4):2134-2147. [PubMed]

Kaplan ID, Meier R. Quality of Life Outcomes for Low-and Intermediate-Risk Prostate Cancer Patients Treated with 5-Fraction Stereotactic Body Radiation Therapy. Int J Radiat Oncol Biol Phys. 2015 Nov;93(3) E249. [redjournal]

Key TJ, Appleby PN, Travis RC, Albanes D, Alberg AJ, Barricarte A, Black A, Boeing H, Bueno-de-Mesquita HB, Chan JM, Chen C, Cook MB, Donovan JL, Galan P, Gilbert R, Giles GG, Giovannucci E, Goodman GE, et al. Carotenoids, retinol, tocopherols, and prostate cancer risk: pooled analysis of 15 studies. Am J Clin Nutr. 2015 Nov; 102(5):1142-57. [Epub 2015 Oct 7] [PubMed]

Meier R, Beckman A., et al. Stereotactic Body Radiation Therapy for Intermediate-Risk Prostate Cancer: Five-Year Outcomes From a Multi-institutional Study. Int J Radiat Oncol Biol Phys. 2015 Nov;93(3)S199. [redjournal]

Meier R. Dose-escalated robotic SBRT for stage I-II prostate cancer. Front Oncol. 2015 Apr 7;5:48. doi: 10.3389/fonc.2015.00048. [eCollection 2015] [PubMed]

Petimar J, Wilson KM, Wu K, Wang M, Albanes D, van den Brandt PA, Cook MB, Giles GG, Giovannucci EL, Goodman GE, Goodman PJ, Håkansson N, Helzlsouer K, Key TJ, Kolonel LN, Liao LM, Männistö S, McCullough ML, Milne RL, Neuhouser ML, Park Y, Platz EA, Riboli E, Sawada N, Schenk JM, Tsugane S, Verhage B, Wang Y, Wilkens LR, Wolk A, Ziegler RG, Smith-Warner SA.  A Pooled Analysis of 15 Prospective Cohort Studies on the Association Between Fruit, Vegetable, and Mature Bean Consumption and Risk of Prostate Cancer.  Cancer Epidemiol Biomarkers Prev.  26(8):1276-87; Aug 2017. pii: cebp.1006.2016. doi: 10.1158/1055-9965.EPI-16-1006. [Epub 26 Apr 2017] [PubMed]

Price AJ, Travis RC, Appleby PN, Albanes D, Barricarte Gurrea A, Bjørge T, Bueno-de-Mesquita HB, Chen C, Donovan J, Gislefoss R, Goodman G, et al. Endogenous Hormones, Nutritional Biomarkers, and Prostate Cancer Collaborative Group.  Circulating Folate and Vitamin B12 and Risk of Prostate Cancer: A Collaborative Analysis of Individual Participant Data from Six Cohorts Including 6875 Cases and 8104 Controls. Eur Urol. 2016 Dec;70(6):941-951. doi: 10.1016/j.eururo.2016.03.029. [Epub 2016 Apr 6] [PubMed]

Wu K, Spiegelman D, Hou T, Albanes D, Allen NE, Berndt SI, van den Brandt PA, Giles GG, Giovannucci E, Goldbohm RA, Goodman G, et al. Associations between unprocessed red and processed meat, poultry, seafood and egg intake and the risk of prostate cancer: A pooled analysis of 15 prospective cohort studies. Int J Cancer. 2016 May 15;138(10):2368-82. [Epub 2015 Dec 19] [PubMed]

Gene Sequencing/Personalized Medicine

Brown TD, Gold PJ, Drescher C, Pagel J, et al. Rapid implementation of a personalized medicine research program (PMRP), using a targeted next-generation sequencing (NGS) assay, in the community setting. J Clin Oncol. 2015;33 (suppl; abstr e22055). [ASCO]

West H. Can we define and reach precise goals for precision medicine in cancer care? J Clin Oncol. 2016;34:3595-3597. [PubMed]

West H. No solid evidence, only a hollow argument for universal tumor sequencing; Show me the data. JAMA Oncol. 2016;2:717-718. [PubMed]

Zhao LP, Fan W, Goodman G, et al. Deciphering Genome Environment Wide Interactions Using Exposed Subjects Only. Genet Epidemiol. 2015 Jul; 39(5):334-46. doi: 10.1002/gepi.21890. [Epub 2015 Feb 18] [PubMed]

Gynecologic Cancer

Bates G, Taub R, West H. Fertility and cancer treatment. JAMA Oncol. 2016;2:284.

Buas MF, Gu H, Djukovic D, Zhu J, Drescher CW, et al. Identification of novel candidate plasma metabolite biomarkers for distinguishing serous ovarian carcinoma and benign serous ovarian tumors. Gynecol Oncol. 2016 Jan;140(1):138-44. doi: 10.1016/j.ygyno.2015.10.021. [Epub 2015 Oct 30] [PubMed]

Celik S, Logsdon BA, Battle S, Drescher CW, et al. Extracting a low-dimensional description of multiple gene expression datasets reveals a potential driver for tumor-associated stroma in ovarian cancer. Genome Med. 2016 Jun 10;8(1):66. doi: 10.1186/s13073-016-0319-7. [PubMed]

Drescher CW, Beatty JD, Resta R, et al. The effect of referral for genetic counseling on genetic testing and surgical prevention in women at high risk for ovarian cancer: Results from a randomized controlled trial. Cancer. 2016 Jul 22. doi: 10.1002/cncr.30190. [Epub ahead of print] [PubMed]

Gregory MT, Bertout JA, Ericson NG, Taylor SD, Mukherjee R, Robins HS, Drescher CW, Bielas JH. Targeted single molecule mutation detection with massively parallel sequencing. Nucleic Acids Res. 2016 Feb 18;44(3):e22. doi:10.1093/nar/gkv915. [Epub 2015 Sep 17] [PubMed]

McIntosh MW, Drescher C, Fitzgibbon MM. Ovarian Cancer Early Detection Needs Better Imaging, Not Better Algorithms or Biomarkers. J Clin Oncol. 2016 Jan 10;34(2):199-200. doi: 10.1200/JCO.2015.63.7843. [Epub 2015 Nov 16] [PubMed]

Richter M, Yumul R, Wang H, Saydaminova K, Ho M, May D, Baldessari A, Gough M, Drescher C, et al. Preclinical safety and efficacy studies with an affinity-enhanced epithelial junction opener and PEGylated liposomal doxorubicin. Mol Ther Methods Clin Dev. 2015 Mar 11;2:15005. doi: 10.1038/mtm.2015.5. [eCollection 2015] [PubMed]

Saydaminova K, Strauss R, Xie M, Bartek J, Richter M, van Rensburg R, Drescher C, et al. Sensitizing ovarian cancer cells to chemotherapy by interfering with pathways that are involved in the formation of cancer stem cells. Cancer Biol Ther. 2016 Oct 2;17(10):1079-1088. [Epub 2016 Aug 30] [PubMed]

Urban N, Hawley S, Janes H, Karlan BY, Berg CD, Drescher CW, et al. Identifying post-menopausal women at elevated risk for epithelial ovarian cancer. Gynecol Oncol. 2015 Nov;139(2):253-60. doi: 10.1016/j.ygyno.2015.08.024. [Epub 2015 Sep 3] [PubMed]

Head and Neck Cancer

Senchak AJ, McKinlay AJ, Acevedo J, Swain B, Tiu MC, et al. The Effect of Tonsillectomy Alone in Adult Obstructive Sleep Apnea. Otolaryngol Head Neck Surg. 2015 May;152(5):969-73. doi: 10.1177/0194599815575721. [Epub 2015 Mar 27] [PubMed]

Sniezek JC.  On-site physician review increases diagnostic accuracy in ultrasound-guided FNA biopsies.  World Thyroid Congress.  Boston, MA.  July 28, 2017.

Tolisano AM, Klem C, Lustik MB, Sniezek JC, Golden JB. Effect of a second primary thyroid carcinoma on patients with head and neck squamous cell carcinoma. Head Neck. 2016 Apr;38 Suppl 1:E890-4. doi: 10.1002/hed.24121. [Epub 2015 Jul 15] [PubMed]

Vincent A., Sniezek JC. A rare case of water clear cell double parathyroid adenoma.  World Thyroid Congress.  Boston, MA.  July 28, 2017.

Hematologic Malignancies

Barr PM, Brown JR, Hillmen P, O'Brien S, Barrientos JC, Reddy NM, Coutre S, Mulligan SP, Jaeger U, Furman RR, Cymbalista F, Montillo M, Dearden C, Robak T, Moreno C, Pagel JM, Burger JA, Suzuki S, Sukbuntherng J, Cole G, James DF, Byrd JC. Impact of ibrutinib dose adherence on therapeutic efficacy in patients with previously treated CLL/SLL. Blood. 2017 May 11;129(19):2612-2615. doi: 10.1182/blood-2016-12-737346. [Epub 2017 Apr 3] [PubMed]

Becker PS, Medeiros BC, Stein AS, Othus M, Appelbaum FR, Forman SJ, Scott BL, Hendrie PC, Gardner KM, Pagel JM, et al. G-CSF Priming, Clofarabine, And High Dose Cytarabine (GCLAC) for Upfront Treatment of Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome or Advanced Myeloproliferative Neoplasm. Am J Hematol. 2015 Apr;90(4):295-300. doi: 10.1002/ajh.23927. [Epub 2015 Jan 30] [PubMed]

Boyiadzis M, Bishop MR, Abonour R, Anderson KC, Ansell SM, Avigan D, Barbarotta L, Barrett AJ, Van Besien K, Bergsagel PL, Borrello I, Brody J, Brufsky J, Cairo M, Chari A, Cohen A, Cortes J, Forman SJ, Friedberg JW, Fuchs EJ, Gore SD, Jagannath S, Kahl BS, Kline J, Kochenderfer JN, Kwak LW, Levy R, de Lima M, Litzow MR, Mahindra A, Miller J, Munshi NC, Orlowski RZ, Pagel JM, Porter DL, Russell SJ, Schwartz K, Shipp MA, Siegel D, Stone RM, Tallman MS, Timmerman JM, Van Rhee F, Waller EK, Welsh A, Werner M, Wiernik PH, Dhodapkar MV.  The Society for Immunotherapy of Cancer Consensus Statement on Immunotherapy for the Treatment of Hematologic Malignancies: Multiple Myeloma, Lymphoma, and Acute Leukemia.  J Immunother Cancer. 2016 Dec 20;4:90. doi: 10.1186/s40425-016-0188-z. [eCollection 2016] [PubMed]

Brown JR, Hallek M, Pagel JM. Chemoimmunotherapy versus targeted treatment in CLL: when, how long, how much, in which combination? In: ASCO Educational Book. 2016;35:e387-98. doi: 10.14694/EDBK_159018. [PubMed]

Brown JR, Hillmen P, O'Brien S, Barrientos JC, Reddy NM, Coutre SE, Tam CS, Mulligan SP, Jaeger U, Barr PM, Furman RR, Kipps TJ, Cymbalista F, Thornton P, Caligaris-Cappio F, Delgado J, Montillo M, DeVos S, Moreno C, Pagel JM, Munir T, Burger JA, Chung D, Lin J, Gau L, Chang B, Cole G, Hsu E, James DF, Byrd JC. Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL. Leukemia. 2018 Jan;32(1):83-91. doi: 10.1038/leu.2017.175. [Epub 2017 Jun 8] [PubMed

Brown JR, O'Brien S, Kingsley CD, Eradat H, Pagel JM, et al. Obinutuzumab (G) Plus Fludarabine/Cyclophosphamide (G-FC) Or Bendamustine (G-B) In The Initial Therapy Of CLL Patients: The Phase 1b GALTON Trial. Blood. 2015 Apr 30;125(18):2779-85. doi: 10.1182/blood-2014-12-613570. [Epub 2015 Mar 13] [PubMed]

Buckley SA, Mawad R, Gooley TA, Becker PS, Sandhu V, Hendrie P, Scott BL, Wood BL, Walter RB, Smith K, Dean C, Estey EH, Pagel JM. A Phase I/II Study Of Oral Clofarabine Plus Low-Dose Cytarabine in Previously Treated Acute Myeloid Leukaemia and High-Risk Myelodysplastic Syndrome Patients at Least 60 Years Of Age. Br J Haematol. 2015 Aug;170(3):349-55. doi: 10.1111/bjh.13437. [Epub 2015 Apr 8] [PubMed]

Byrd JC, Harrington B, O'Brien S, Jones JA, Schuh A, Devereux S, Chaves J, Wierda WG, Awan FT, Brown JR, Hillmen P, Stephens DM, Ghia P, Barrientos JC, Pagel JM, et al. Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia. N Engl J Med. 2016 Jan 28;374(4):323-32. doi: 10.1056/NEJMoa1509981. [Epub 2015 Dec 7] [PubMed]

Cassaday RD, Stevenson PA, Gooley TA, Chauncey TR, Pagel JM, Rajendran J, Till BG, Philip M, Orozco JJ, Bensinger WI, et al. High-Dose CD20-Targeted Radioimmunotherapy-Based Autologous Transplantation Improves Outcomes for Persistent Mantle Cell Lymphoma. Br J Haematol. 2015 Dec;171(5):788-97. doi: 10.1111/bjh.13773. [Epub 2015 Oct 12] [PubMed]

Cassaday RD, Storer BE, Sorror ML, Sandmaier BM, Guthrie KA, Maloney DG, Rajendran JG, Pagel JM, et al. Long-Term Outcomes Of Patients with Persistent Indolent B-Cell Malignancies Undergoing Nonmyeloablative Allogeneic Transplantation. Biol Blood Marrow Transplant. 2015 Feb;21(2):281-7. doi: 10.1016/j.bbmt.2014.10.024. [Epub 2014 Nov 1] [PubMed]

Chen X, Newell LF, Xie H, Walter RB, Pagel JM, et al. Low Platelet Count Reduces Subsequent Complete Remission Rate Despite Marrow With <5% Blasts After AML Induction Therapy. Leukemia. 2015 Aug;29(8):1779-80. doi: 10.1038/leu.2015.23. [Epub 2015 Feb 4] [PubMed]

Chen X, Xie H, Wood BL, Walter RB, Pagel JM, et al. Relation of Clinical Response and Minimal Residual Disease and their Prognostic Impact on Outcome in Acute Myeloid Leukemia. J Clin Oncol. 2015 Apr 10;33(11):1258-64. doi: 10.1200/JCO.2014.58.3518. [Epub 2015 Mar 2] [PubMed]

Coutre SE, Barrientos JC, Brown JR, de Vos S, Furman RR, Keating MJ, Li D, O'Brien SM, Pagel JM, et al. Management of Adverse Events Associated with Idelalisib Treatment - Expert Panel Opinion. Leuk Lymphoma. 2015;56(10):2779-86. doi: 10.3109/10428194.2015.1022770. [Epub 2015 May 19] [PubMed]

Coutre SE, Burger JA, Pagel JM. Discussion: Managing Risk when using Idelalisib.  In: Clinical Advances in Hematology Oncology. 14(5 Suppl 8):13, 2016. [PubMed]

Cowan AJ, Frayo SL, Press OW, Palanca-Wessels MC, Pagel JM, et al. Bortezomib And Fenretinide Induce Synergistic Cytotoxicity in Mantle Cell Lymphoma Through Apoptosis, Cell-Cycle Dysregulation, and Iκbα Kinase Downregulation. Anticancer Drugs. 2015 Oct;26(9):974-83. doi: 10.1097/CAD.0000000000000274. [PubMed]

Cowan AJ, Stevenson PA, Gooley TA, Frayo SL, Oliveira GR, Smith SD, Green DJ, Roden JE, Pagel JM, Wood BL, Press OW, Gopal AK. Results of a Phase I-II Study of Fenretinide and Rituximab for Patients with Indolent B-Cell Lymphoma and Mantle Cell Lymphoma.  Br J Haematol. 2017 Feb;176(4):583-590. doi: 10.1111/bjh.14451. [Epub 2017 Jan 5] [PubMed]

Davids MS, Roberts AW, Seymour JF, Pagel JM, Kahl BS, Wierda WG, Puvvada S, Kipps TJ, Anderson MA, Salem AH, Dunbar M, Zhu M, Peale F, Ross JA, Gressick L, Desai M, Kim SY, Verdugo M, Humerickhouse RA, Gordon GB, Gerecitano JF. Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma. J Clin Oncol. 2017 Mar 10;35(8):826-833. doi: 10.1200/JCO.2016.70.4320. [Epub 2017 Jan 17] [PubMed]

Frost SH, Frayo SL, Miller BW, Orozco JJ, Booth GC, Hylarides MD, Lin Y, Green DJ, Gopal AK, Pagel JM, et al. Comparative Efficacy of 177Lu and 90Y for Anti-CD20 Pretargeted Radioimmunotherapy in Murine Lymphoma Xenograft Models. PLoS One. 2015 Mar 18;10(3):e0120561. doi: 10.1371/journal.pone.0120561. [eCollection 2015] [PubMed]

Frost SH, Miller BW, Bäck TA, Santos EB, Hamlin DK, Knoblaugh SE, Frayo SL, Kenoyer AL, Storb R, Press OW, Wilbur DS, Pagel JM, Sandmaier BM. α-Imaging Confirmed Efficient Targeting of CD45-Positive Cells After 211At-Radioimmunotherapy for Hematopoietic Cell Transplantation. J Nucl Med. 2015 Nov;56(11):1766-73. doi: 10.2967/jnumed.115.162388. [Epub 2015 Sep 3] [PubMed]

Graf SA, Stevenson PA, Holmberg LA, Till BG, Press OW, Chauncey TR, Smith SD, Philip M, Orozco JJ, Shustov AR, Green DJ, Libby EN 3rd, Bensinger WI, Pagel JM, et al. Maintenance Rituximab after Autologous Stem Cell Transplantation in Patients with Mantle Cell Lymphoma. Ann Oncol. 2015 Nov;26(11):2323-8. doi: 10.1093/annonc/mdv364. [Epub 2015 Sep 7] [PubMed]

Green DJ, Bensinger WI, Holmberg LA, Gooley T, Till BG, Budde LE, Pagel JM, et al. Bendamustine, Etoposide and Dexamethasone to Mobilize Peripheral Blood Hematopoietic Stem Cells for Autologous Transplantation in Patients with Multiple Myeloma. Bone Marrow Transplant. 2016 Oct;51(10):1330-1336. doi: 10.1038/bmt.2016.123. [Epub 2016 May 23] [PubMed]

Green DJ, Shadman M, Jones JC, Frayo SL, Kenoyer AL, Hylarides MD, Hamlin DK, Wilbur DS, Balkan ER, Lin Y, Miller B, Frost SHL, Goal AK, Orozco JJ, Gooley TA, Laird KL, Bäck T, Sandmaier BM, Pagel JM, Press OW. Astatine Conjugated to an Anti-CD20 Monoclonal Antibody Eradicates Dissmeninated B-cell Lymphoma in a Mouse Model. Blood. 2015 Mar 26;125(13):2111-9. doi: 10.1182/blood-2014-11-612770. [Epub 2015 Jan 27] [PubMed]

Loeb KR, Cherian S, Becker PS, Walter RB, Pagel JM, et al. Comparative analysis of flow cytometry and morphology for the detection of acute myeloid leukaemia cells in cerebrospinal fluid. Br J Haematol. 2016 Jan;172(1):134-6. doi: 10.1111/bjh.13465. [Epub 2015 May 26] [PubMed]

Mato AR, Thompson M, Allan JN, Brander DM, Pagel JM, Ujjani CS, Hill BT, Lamanna N, Lansigan F, Jacobs R, Shadman M, Skarbnik AP, Pu JJ, Barr PM, Sehgal AR, Cheson BD, Zent CS, Tuncer HH, Schuster SJ, Pickens PV, Shah NN, Goy A, Winter AM, Garcia C, Kennard K, Isaac K, Dorsey C, Gashonia LM, Singavi AK, Roeker LE, Zelenetz A, Williams A, Howlett C, Weissbrot H, Ali N, Khajavian S, Sitlinger A, Tranchito E, Rhodes J, Felsenfeld J, Bailey N, Patel B, Burns TF, Yacur M, Malhotra M, Svoboda J, Furman RR, Nabhan C. Real world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States. Haematol. doi: 10.3324/haematol.2018.193615. [Epub 2018 Jun 7] [PubMed]

Mawad R, Becker PS, Hendrie P, Scott B, Wood BL, Dean C, Sandhu V, Deeg HJ, Walter R, Wang L, Myint H, Singer JW, Estey E, Pagel JM. Phase II Study of Tosedostat with Cytarabine or Decitabine in Newly Diagnosed Older Patients with Acute Myeloid Leukaemia or High-Risk MDS. Br J Haematol. 2016 Jan;172(2):238-45. doi: 10.1111/bjh.13829. [Epub 2015 Nov 16] [PubMed]

Miller BW, Frost SH, Frayo SL, Kenoyer AL, Santos E, Jones JC, Green DJ, Hamlin DK, Wilbur DS, Fisher DR, Orozco JJ, Press OW, Pagel JM, Sandmaier BM. Quantitative Single-Particle Digital Autoradiography with Α-Particle Emitters for Targeted Radionuclide Therapy Using The Iqid Camera. Med Phys. 2015;42(7):4094. [PubMed]

Orozco JJ, Kenoyer A, Balkin ER, Gooley TA, Hamlin DK, Wilbur DS, Hylarides MD, Frost SH, Mawad R, O'Donnell P, Sandmaier BM, Fuchs EJ, Luznik L, Green DJ, Gopal AK, Press OW, Pagel JM. Anti-CD45 Radioimmunotherapy without TBI before BMT Facilitates Persistent Haploidentical Donor Engraftment in a Murine Model. Blood. 2016 Jan 21;127(3):352-9. doi: 10.1182/blood-2014-12-617019. [Epub 2015 Nov 17] [PubMed]

Pagel JM.  A Richter transformation PD-1 block party. In: Blood. 2017 Jun 29;129(26):3397-3398. doi: 10.1182/blood-2017-05-781229. [PubMed]

Pagel JM. Initiation of Treatment in Chronic Lymphocytic Leukemia. Clinical Advances in Hematology Oncology. 14(5 Suppl 8):3-5, 2016.

Pagel JM.  Neighborhood Imbalances: Overcoming MCL Drug Resistance. Blood. 128(24):2752-2753, 2016. [PubMed]

Pagel JM, Spurgeon SE, Byrd JC, et al. Otlertuzumab (TRU-016), An Anti-CD37 Monospecific ADAPTIR™ Therapeutic Protein, for Relapsed or Refractory NHL Patients. Br J Haematol. 2015 Jan;168(1):38-45. doi: 10.1111/bjh.13099. [Epub 2014 Aug 22] [PubMed]

Pagel JM, West HJ.  Chimeric Antigen Receptor (CAR) T-Cell Therapy. In: JAMA Oncol. 2017 Nov 1;3(11):1595. doi: 10.1001/jamaoncol.2017.2989. [PubMed]

Patel K, West HJ. Febrile Neutropenia. JAMA Oncol. 2017 Dec 1;3(12):1751. doi: 10.1001/jamaoncol.2017.1114. [PubMed]

Robak T, Hellman A, Kloczko J, Loscertales J, Lech-Maranda E, Pagel JM, Mato A, Byrd JC, Awan FT, Hebart H, Garcia-Marco JA, Hill BT, Hallek M, Eisenfeld AJ,Stromatt SC, Jaeger U. Randomized Phase 2 Study of Otlertuzumab and Bendamustine versus Bendamustine in Patients with Relapsed Chronic Lymphocytic Leukaemia. Br J Haematol. 2017 Feb;176(4):618-628. doi: 10.1111/bjh.14464. [Epub 2016 Dec 15] [PubMed]

Roberts AW, Davids MS, Pagel JM, et al. Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia. N Engl J Med. 2016 Jan 28;374(4):311-22. doi: 10.1056/NEJMoa1513257. [Epub 2015 Dec 6] [PubMed]

Shadman M, Gopal AK, Kammerer B, Becker PS, Maloney DG, Pender B, Shustov AR, Press OW, Pagel JM. Radioimmunotherapy Consolidation using 131I-Tositumomab for Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in First Remission. Leuk Lymphoma. 2016;57(3):572-6. doi: 10.3109/10428194.2015.1067701. [Epub 2015 Aug 28] [PubMed]

Shadman M, Hingorani S, Lanum SA, Pagel JM, et al. Allogeneic Hematopoietic Cell Transplants for Patients with End Stage Renal Disease Requiring Dialysis – A Single Institution Experience. Leuk Lymphoma. 2017 Mar;58(3):740-742. doi: 10.1080/10428194.2016.1211280. [Epub 2016 Jul 25] [PubMed]

Shadman M, Mawad R, Dean C, Chen TL, Shannon-Dorcy K, Sandhu V, Hendrie PC, Scott BL, Walter RB, Becker PS, Pagel JM, Estey EH. Idarubicin, Cytarabine, and Pravastatin as Induction Therapy for Untreated Acute Myeloid Leukemia And High-Risk Myelodysplastic Syndrome. Am J Hematol. 2015 Jun;90(6):483-6. doi: 10.1002/ajh.23981. [Epub 2015 Feb 27] [PubMed]

Tong, WG, Sandu VK, Wood BL, Hendrie PC, Becker PS, Pagel JM, et al. Correlation Between Peripheral Blood and Bone Marrow Regarding Flt3-Itd and Npm1 Mutational Status in Patients with Acute Myeloid Leukemia. Haematologica. 2015 Mar;100(3):e97-8. doi: 10.3324/haematol.2014.118422. [Epub 2014 Dec 19] [PubMed]

Walter RB, Gyurkocza B, Storer BE, Godwin CD, Pagel JM, et al. Comparison Of Minimal Residual Disease as Outcome Predictor for AML Patients in First Complete Remission Undergoing Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation. Leukemia. 2015 Jan;29(1):137-44. doi: 10.1038/leu.2014.173. [Epub 2014 Jun 3] [PubMed]

Walter RB, Sandmaier BM, Storer BE, Godwin CD, Buckely SA, Pagel JM, et al. Number of Courses of Induction Therapy Independently Predicts Outcome after Allogeneic Transplantation for AML in First Morphological Remission. Biol Blood Marrow Transplant. 2015 Feb;21(2):373-8. doi: 10.1016/j.bbmt.2014.09.022. [Epub 2014 Sep 30] [PubMed]

Yezefski T, Xie H, Walter RB, Pagel J, et al. Value of Routine "Day 14" Marrow Exam in Newly-Diagnosed AML. Leukemia. 2015 Jan;29(1):247-9. doi: 10.1038/leu.2014.268. [Epub 2014 Sep 10] [PubMed]

Neurological Cancer

Cobbs C. Reply to: Towards an unbiased, collaborative effort to reach evidence about the presence of human cytomegalovirus in glioblastoma (and other tumors). Neuro Oncol. 2015 Jul;17(7):1040. doi: 10.1093/neuonc/nov077. [PubMed]

Fisahn C, Moisi MD, Jeyamohan S, Wingerson M, Tubbs RS, Cobbs CS, Oskouian RJ, Chapman JR. Cervical fracture from chronic steroid usage presenting as a stroke: A case report. Int J Surg Case Rep. 2016;28:135-138. doi: 10.1016/j.ijscr.2016.09.042. PMID: 27701004 [Epub 2016 Sep 29] [PubMed]

Foster H, Ulasov IV, Cobbs CS. Human cytomegalovirus-mediated immunomodulation: Effects on glioblastoma progression. Biochim Biophys Acta. 2017 Aug;1868(1):273-276. doi: 10.1016/j.bbcan.2017.05.006. PMID: 28554666 [Epub 2017 May 26] [PubMed]

Ghosh D, Funk CC, Caballero J, Shah N, Rouleau K, Earls JC, Soroceanu L, Foltz G, Cobbs CS, Price ND, Hood L. A Cell-Surface Membrane Protein Signature for Glioblastoma. Cell Syst. 2017 May 24;4(5):516-529.e7. doi: 10.1016/j.cels.2017.03.004. PMID:28365151 [Epub 2017 Mar 29] [PubMed]

Ghosh D, Ulasov IV, Chen L, Harkins LE, Wallenborg K, Hothi P, Rostad S, Hood L, Cobbs CS. TGFB-Responsive HMOX1 Expression Is Associated with Stemness and Invasion in Gioblastoma Multiforme.  Stem Cells. 2016 Sep;34(9):2276-89. doi: 10.1002/stem.2411. [Epub 2016 Jul 4] [PubMed]

Joseph GP, McDermott R, Baryshnikova MA, Cobbs CS, Ulasov IV. Cytomegalovirus as an oncomodulatory agent in the progression of glioma. Cancer Lett. 2017 Jan 1;384:79-85. doi: 10.1016/j.canlet.2016.10.022. PMID: 27777041. [Epub 2016 Oct 21] [PubMed]

Lin B, Lee H, Yoon JG, Madan A, Wayner E, Tonning S, Hothi P, Schroeder B, Ulasov I, Foltz G, Hood L, Cobbs C. Global analysis of H3K4me3 and H3K27me3 profiles in glioblastoma stem cells and identification of SLC17A7 as a bivalent tumor suppressor gene. Oncotarget. 2015 Mar 10;6(7):5369-81. [PubMed]

Ngô HM, Zhou Y, Lorenzi H, Wang K, Kim TK, Zhou Y, Bissati KE, Mui E, Fraczek L, Rajagopala SV, Roberts CW, Henriquez FL, Montpetit A, Blackwell JM, Jamieson SE, Wheeler K, Begeman IJ, Naranjo-Galvis C, Alliey-Rodriguez N, Davis RG, Soroceanu L, Cobbs C, Steindler DA, Boyer K, Noble AG, Swisher CN, Heydemann PT, Rabiah P, Withers S, Soteropoulos P, Hood L, McLeod R. Toxoplasma Modulates Signature Pathways of Human Epilepsy, Neurodegeneration & Cancer. Sci Rep. 2017 Sep 13;7(1):11496. doi: 10.1038/s41598-017-10675-6. PMID:28904337 [PubMed]

Schroeder B, Shah N, Rostad S, McCullough B, Aguedan B, Foltz G, Cobbs CS. Genetic investigation of multicentric glioblastoma multiforme: case report.  J Neurosurg. 2016 May;124(5):1353-8. doi: 10.3171/2015.4.JNS142231. [Epub 2015 Oct 16] [PubMed]

Soroceanu L, Matlaf L, Khan S, Akhavan A, Singer E, Bezrookove V, Decker S, Ghanny S, Hadaczek P, Bengtsson H, Ohlfest J, Luciani-Torres MG, Harkins L, Perry A, Guo H, Soteropoulos P, Cobbs CS. Cytomegalovirus Immediate-Early Proteins Promote Stemness Properties in Glioblastoma. Cancer Res. 2015 Aug 1;75(15):3065-76. doi: 10.1158/0008-5472.CAN-14-3307. [PubMed]

Ulasov I, Borovjagin AV, Kaverina N, Schroeder B, Shah N, Lin B, Baryshnikov A, Cobbs C. MT1-MMP silencing by an shRNA-armed glioma-targeted conditionally replicative adenovirus (CRAd) improves its anti-glioma efficacy in vitro and in vivo. Cancer Lett. 2015 Sep 1;365(2):240-50. doi: 10.1016/j.canlet.2015.06.002. Epub 2015 Jun 4. [PubMed]

Ulasov IV, Foster H, Butters M, Yoon JG, Ozawa T, Nicolaides T, Figueroa X, Hothi P, Prados M, Butters J, Cobbs C. Precision knockdown of EGFR gene expression using radio frequency electromagnetic energy. J Neurooncol. 2017 Jun;133(2):257-264. doi: 10.1007/s11060-017-2440-x. PMID:28434113 [Epub 2017 Apr 22] [PubMed]

Ulasov IV, Kaverina NV, Ghosh D, Baryshnikova MA, Kadagidze ZG, Karseladze AI, Baryshnikov AY, Cobbs CS. CMV70-3P miRNA contributes to the CMV mediated glioma stemness and represents a target for glioma experimental therapy. Oncotarget. 2017 Apr 18;8(16):25989-25999. doi: 10.18632/oncotarget.11175. PMID: 27517625 [Epub 2016 Aug 10] [PubMed]

Ulasov IV, Shah N, Kaverina NV, Lee H, Lin B, Lieber A, Kadagidze ZG, Yoon JG, Schroeder B, Hothi P, Ghosh D, Baryshnikov AY, Cobbs CS. Tamoxifen improves cytopathic effect of oncolytic adenovirus in primary glioblastoma cells mediated through autophagy. Oncotarget. 2015 Feb 28;6(6):3977-87. [PubMed]

Practice Management

Polite B, Ward JC, Cox JV, et al. A Pathway Through the Bundle Jungle. J Oncol Pract, 2016 Jun;12(6):504-9. doi: 10.1200/JOP.2015.008789. [Epub 2016 May 12] [PubMed]

Polite BN, Conti RM, Ward JC. Reform of the Buy-and-Bill System for Outpatient Chemotherapy Care is Inevitable: Perspectives from an Economist, a Realpolitik, and an Oncologist. Am Soc Clin Oncol Educ Book. 2015:e75-80. doi: 10.14694/EdBook_AM.2015.35.e75. [PubMed]

Polite BN, Ward JC, Cox JV, et al. Reply to M. Thompson, et al. J Oncol Pract. 2015 May;11(3):263-4. doi: 10.1200/JOP.2015.003897. [Epub 2015 Mar 3] [PubMed]

Thomas CA, Ward JC. The Oncology Care Model: A Critique. Am Soc Clin Oncol Educ Book. 2016;35:e109-14. doi: 10.14694/EDBK_156883. [PubMed]

Supportive Care

Alfano CM, Zucker DZ, Pergolotti M, Ness KK, Jones L, Price ND. Schmitz KH, Ligibel JA.  A Precision Medicine Approach to Improve Cancer Rehabilitation’s Impact and Integration with Cancer Care and Optimize Patient Wellness.  Current Physical Medicine and Rehabilitation Reports, 2017, 1-10.[Epub 2017 Feb 16] [Springer]

Cheville AL, Mustian K, Winters-Stone K, Zucker DS, et al. Cancer Rehabilitation: An Overview of Current Need, Delivery Models, and Levels of Care. Phys Med Rehabil Clin N Am. 2017 Feb;28(1):1-17. doi: 10.1016/j.pmr.2016.08.001. [PubMed]

Decker VB, Howard GS, Holdread H, et al. Piloting an Automated Distress Management Program in an Oncology Practice. Clin J Oncol Nurs. 2016 Feb;20(1):E9-E15. doi: 10.1188/16.CJON.E9-E15. [PubMed]

Lee JK, Mendoza DM, Mohler J, Lee EM. Geriatrics. In: Chisholm-Burns MA, Wells BG, Schwinghammer TL, et al., eds. Pharmacotherapy: principles and practice. 4th ed. New York City: McGraw-Hill, Inc. 2015.

Rhodes SM, Gabbard J, Chaudhary, A, Ketterer B, Lee EM. Palliative Care in Cancer. In: Alberts D, Weihs K, Lluria-Prevatt M, eds. Supportive Cancer Care. New York, NY: Springer. 2015. 77-95.

Wynn, JD. Difficult personality traits and disorders in cancer care. In: Holland JC, et al. Psycho-Oncology, 3rd ed. Oxford University Press. 2015. 10.1093/med/9780199363315.003.0045.

Thoracic Cancer

Achim V, Aye RW, Farivar AS, Vallières E, Louie BE. A Combined Thoracoscopic and Laparoscopic Approach for High Epiphrenic Diverticula and the Importance of Complete Myotomy. Surg Endosc. 2016 Jul 12. [Epub ahead of print] [PubMed]

Aye RW, Qureshi AP, Wilshire CL, Farivar AS, Vallières E, Louie BE. Feasibility, Safety, and Short-term Efficacy of the Laparoscopic Nissen-Hill Hybrid Repair. Surg Endoscopy. 2016;30(2):551-558. [PubMed]

Bazhenova L,  Hodgson JG, Langer CJ, Simon GR, Gettinger SN, Ou S-HI, Reckamp KL, West HJ, Chiappori A, Koh HA, Molina JR, Shaw AT, Patel JD, Favaro JP, Haney J, Reichmann W, Kerstein D, Rivera VM, Camidge DR. Activity of brigatinib (BRG) in crizotinib (CRZ)-resistant ALK+ NSCLC patients (pts) according to ALK plasma mutation status. J Clin Oncol 34, 2017 (suppl; abstr 9065).  [ASCOpubs]

Belanger A, Nguyen K, Osman U, Gilbert CR,  Allen K, Al Rasis, A, Yarmus L, Akulian J. Pleural Effusions in Non-Transplanted Cystic Fibrosis Patients. Journal of Cystic Fibrosis. 2017; 16(4): 499-502. doi: 10.1016/ j.jcf.2016.11.006.  [PubMed]

Bellevue OC, Louie BE, Jutric Z, Farivar AS, Aye RW. A Hill Gastropexy Combined with Nissen Fundoplication Appears Equivalent to a Collis-Nissen in the Management of Short Esophagus. J Gastrointest Surg. (2017). 2018 Mar;22(3):389-395. doi: 10.1007/s11605-017-3598-4. [Epub 2017 Oct 2] [PubMed]

Bharadwaj SC, Vallières E, Wilshire CL, Blitz M, Page B, Aye RW, Farivar AS, Louie BE. Higher Versus Standard Preoperative Radiation in the Trimodality Treatment of Stage IIIa Lung Cancer. Ann of Thorac Surg. 2015 Jul;100(1):207-13; discussion 213-4. doi: 10.1016/j.athoracsur.2015.03.075. [Epub 2015 Jun 2] [PubMed]

Boys JA, Worrell SG, Chandrasoma P, Dunst CM, Hofstetter WL, Louie BE, et al. Can the Risk of Lymph Node Metastases Be Gauged in Endoscopically Resected Submucosal Esophageal Adenocarcinomas? A Multi-Center Study. J Gastrointest Surg. 2016 Jan;20(1):6-12; discussion 12. doi: 10.1007/s11605-015-2950-9. [Epub 2015 Sep 25] [PubMed]

Bradley DD, Louie BE, Baik P, Farivar AS, Aye RW. Assessment and Reduction Of Diaphragmatic Tension During Hiatal Hernia Repair. Surg Endosc. 2015 Apr;29(4):796-804. doi: 10.1007/s00464-014-3744-y. [Epub 2014 Jul 24] [PubMed]

Bradley DD, Louie BE, Chen J, Aye RW, McMahon R, Farivar AS. The effect of concurrent esophageal pathology on bariatric surgical planning. J Gastrointest Surg. 2015 Jan;19(1):111-5; discussion 115-6. doi: 10.1007/s11605-014-2626-x. [Epub 2014 Sep 12] [PubMed]

Brenner DR, Amos CI, Brhane Y, Timofeeva MN, Caporaso N, Wang Y, Christiani DC, Bickeböller H, Yang P, Albanes D, Stevens VL, Gapstur S, McKay J, Boffetta P, Zaridze D, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Mates D, Bencko V, Foretova L, Janout V, Krokan HE, Skorpen F, Gabrielsen ME, Vatten L, Njølstad I, Chen C, Goodman G, et al. Identification of lung cancer histology-specific variants applying Bayesian framework variant prioritization approaches within the TRICL and ILCCO consortia. Carcinogenesis. 2015 Nov;36(11):1314-26. doi: 10.1093/carcin/bgv128. [Epub 2015 Sep 10] [PubMed]

Brown LM, Louie BE. Robot-Assisted Total Thymectomy: How I Teach It. Ann Thorac Surg. 2017 Feb;103(2):369-372. doi: 10.1016/j.athoracsur.2016.11.058. [PubMed]

Brown LM, Louie BE, Jackson NK, Farivar AS, Aye RW, Vallières E. Recurrence And Survival After Segmentectomy In Patients With Prior Lung Resection For Early Stage Non-Small Cell Lung Cancer. Ann Thorac Surg. 2016 Oct;102(4):1110-8. doi: 10.1016/j.athoracsur.2016.04.037. [Epub 2016 Jun 24] [PubMed]

Carreras-Torres R, Haycock PC, Relton CL, Martin RM, Smith GD, Kraft P, Gao C, Tworoger S, Le Marchand L, Wilkens LR, Park SL, Haiman C, Field JK, Davies M, Marcus M, Liu G, Caporaso NE, Christiani DC, Wei Y, Chen C, Doherty JA, Severi G, Goodman GE, et al. The causal relevance of body mass index in different histological types of lung cancer: A Mendalian randomization study. Sci Rep. 2016 Aug 4;6:31121. doi: 10.1038/srep31121. [PubMed]

Carreras-Torres R, Johansson M, Haycock PC, Wade KH, Relton CL, Martin RM, Davey Smith G, Albanes D, Aldrich MC, Andrew A, Arnold SM, Bickeböller H, Bojesen SE, Brunnström H, Manjer J, Brüske I, Caporaso NE, Chen C, Christiani DC, Christian WJ, Doherty JA, Duell EJ, Field JK, Davies MPA, Marcus MW, Goodman GE, Grankvist K, Haugen A, Hong YC, Kiemeney LA, van der Heijden EHFM, Kraft P, Johansson MB, Lam S, Landi MT, Lazarus P, Le Marchand L, Liu G, Melander O, Park SL, Rennert G, Risch A, Haura EB, Scelo G, Zaridze D, Mukeriya A, Savić M, Lissowska J, Swiatkowska B, Janout V, Holcatova I, Mates D, Schabath MB, Shen H, Tardon A, Teare MD, Woll P, Tsao MS, Wu X, Yuan JM, Hung RJ, Amos CI, McKay J, Brennan P.  Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study.  PLoS One. 2017 Jun 8;12(6):e0177875. doi: 10.1371/journal.pone.0177875. [PubMed]

Castiglioni M, Louie BE, Wilshire CL, Farivar AS, Aye RW, Gorden J, Horton MP, Vallières E. Surveillance Of The Remaining Nodules After Resection Of The Dominant Lesion In Patients With Multiple Nodules And A Dominant Lung Adenocarcinoma Is An Appropriate Follow Up Strategy. Front Surg. 2015 Jan 12;1:52. doi: 10.3389/fsurg.2014.00052. [PubMed]

Castiglioni M, Louie BE, Wilshire CL, Farivar AS, Aye RW, Gorden J, Horton MP, Vallières E. Patients With Multiple Nodules And A Dominant Lung Adenocarcinoma Have Similar Outcomes And Survival Compared With Patients Who Have A Single Dominant Adenocarcinoma. Interact Cardiovasc Thorac Surg. 2015;20:229-235. [Oxford Academic]

Cattoni M, Vallières E,  Brown LM, Sarkeshik AA, Margaritora S, Siciliani A, Imperatori A, Rotolo N, Farjah F, Wandell G, Costas K, Mann C, Hubka M, Kaplan S, Farivar AS, Aye RW, Louie BE. Is there a role for traditional nuclear medicine imaging in the management of pulmonary carcinoid tumors? Eur J Cardiothoracic Surg. 2017 May 1;51(5):874-879. doi: 10.1093/ejcts/ezw422. [PubMed]

Cattoni M, Vallières E,  Brown LM, Sarkeshik AA, Margaritora S, Siciliani A, Imperatori A, Rotolo N, Farjah F, Wandell G, Costas K, Mann C, Hubka M, Kaplan S, Farivar AS, Aye RW, Louie BE. External validation of a prognostic model of survival for 1 resected typical bronchial carcinoid tumors. Ann Thor Surg. 2017 Oct;104(4):1215-1220. doi:10.1016/j.athoracsur.2017.05.019. [Epub 2017 Aug 16] [PubMed]

Cattoni M, Vallières E, Brown LM, Sarkeshik AA, Granone P, Siciliani A, Dominioni L, Imperatori A, Farjah F, Wandell G, Costas K, Mann C, Hubka M, Kaplan S, Farivar AS, Aye RW, Brian E. Louie.  Improvements in TNM Staging of Pulmonary Neuroendocrine Tumors. Requires Histology and Regrouping of Tumor Size. J Thoracic Cardiovasc Surg. 2018 Jan;155(1):405-413. doi: 10.1016/j.jtcvs.2017.08.102. [Epub 2017 Sep 9] [PubMed]

Cerfolio RJ, Louie BE, Farivar AS, Onaitis M, Park BJ.  Consensus Statement On Definitions and Nomenclature for Robotic Thoracic Surgery.  Journal of Thoracic and Cardiovascular Surgery. 2017 Sep;154(3):1065-1069. doi: 10.1016/j.jtcvs.2017.02.081. [Epub 2017 May 23] [PubMed]

Colombara DV, Manhart LE, Carter JJ, Hawes SE, Weiss NS, Hughes JP, Barnett MJ, Goodman GE, et al. Prior human polyomavirus and papillomavirus infection and incident lung cancer: a nested case-control study. Cancer Causes Control. 2015 Dec;26(12):1835-44. doi: 10.1007/s10552-015-0676-3. [Epub 2015 Sep 28] [PubMed]

Fang W, Yao X, Antonicelli A, Louie BE, Gu Z, Vallières E, Huang J, Korst R, Detterbeck F. Comparison of Surgical Approach and Extent of Resection for Masaoka-Koga Stage I and II Thymic Tumors in Europe, North America and Asia: an ITMIG Retrospective Database Analysis. Eur J Cardiothorac Surg. 2017 Jul 1;52(1):26-32. doi: 10.1093/ejcts/ezx042. [PubMed]

Fathi JT, Blanshan S, Wilson AS, Wilshire CL, Gilbert CR, Carlson, AS, Aye RW, Farivar AS, Louie BE, Vallières E, Gorden JA. Integrating smoking cessation counselling and treatment in a lung cancer screening program: an effective approach to long-term smoking cessation success. The American Thoracic Society. Washington DC; May 23, 2017. [ATSJournals]

Feczko A, Mckeown E, Wilson JL, Louie BE, Aye RW, Gorden JA, Vallieres E, Farivar AS.  Assessing Survival and Grading the Severity of Complications in Octogenarians Undergoing Pulmonary Lobectomy.  Can Respir J. 2017:6294895. doi: 10.1155/2017/6294895. [Epub 2017 Feb 8] [PubMed]

Gilbert CR, Abendroth C, Yarmus L. The Intranodal Presence of Coexisting Granulomatous Inflammation and Carcinoma during Transbronchial Needle Aspiration of Intrathoracic Lymphadenopathy. J Bronchology Interv Pulmonol. 2017 Jan;24(1):80-83. [PubMed]

Gilbert CR, Akullian JA, Gorden JA. The Impact of the ASAP Trial: Maybe We Shouldn’t Act So Quickly. Am J Respir Crit Care Med. 2018 Jan 1;197(1):142-143. doi: 10.1164/rccm.201705-0956LE. [PubMed]

Gilbert CR, Fathi JT, Ely R, Wilshire CL, Louie BE, Aye RW, Farivar AS, Vallières E, Gorden JA.  The Economic Impact of a Nurse Practitioner Directed Lung Cancer Screening, Incidental Pulmonary Nodule, and Tobacco Cessation Clinic accepted for publication. J Thorac Cardiovasc Surg. 2018 Jan;155(1):416-424. doi: 10.1016/j.jtcvs.2017.07.086. [Epub 2017 Sep 13] [PubMed]

 

Gilbert C, Feller-Kopman D. Adjunct strategies to enhance the efficacy of indwelling pleural catheters. Curr Pulmonol Rep. 2015;4: 28-33. doi: 10.1007/s13665-015-0110-z. [ResearchGate]

Gilbert CR., Gorden JA. Use of intrapleural tissue plasminogen activator and deoxyribonuclease in pleural space infections: an update on alternative regimens. Curr Opin Pulm Med. 2017 Jul;23(4):371-375. doi: 10.1097/MCP.0000000000000387 [PubMed]

Gilbert C, Haouzi P. Noninvasive Positive Pressure Ventilation in Acute Respiratory Failure. In: Basner RC, Parthasarathy S, eds. Nocturnal Non-Invasive Ventilation: Theory, Evidence, and Clinical Practice. New York, NY: Springer. 2015. 247-269.

Gilbert C, Lee H, Akulian J, et al. A Quality Improvement Intervention to Reduce Indwelling Tunneled Pleural Catheter Infection Rates. Ann Am Thorac Soc. 2015;12(6):847-853. doi: 10.1513/AnnalsATS.201411-511OC. [PubMed]

Gilbert C, Lee H, Skalski J, Maldonado F, Wahidi M, Choi P, Bessich J, Sterman D, Argento AC, Shojaee S, Gorden J, et al. The Use of Indwelling Tunneled Pleural Catheters for Recurrent Pleural Effusions in Patients with Hematologic Malignancies: A Multicenter Study. Chest. 2015;148(3):752-758. doi: 10.1378/chest.14-3119. [PubMed]

Gilbert C, Toth, Osman U, Reed M. Endobronchial Valve Placement as Destination Therapy for Recurrent Pneumothorax in the Setting of Advanced Malignancy. Respir Care. 2015 Mar;60(3):e46-8. doi: 10.4187/respcare.03540. [Epub 2014 Oct 21] [PubMed]

Gilbert, CR, Casal RF; Feller-Kopman D; Lee HJ; Frimpong B, Dincer HE, Podgaetz E, Benzaquen S, Majid, A, Folch, E, Gorden JA, et al. Use of One-Way Intrabronchial Valves in the Management of Air Leaks After Tube Thoracostomy Drainage. Ann Thorac Surg. 2016 May;101(5):1891-6. doi: 10.1016/j.athoracsur.2015.10.113. [Epub 2016 Feb 12] [PubMed]

Gilbert CR, Yarmus LB, Feller-KopmanDJ, Lee HJ, Gorden JA. The Undefined Value of Pleural Interventions in Advanced Heart Failure and Recurrent Pleural Effusions. Ann Am Thorac Soc. 2016 Mar;13(3):447-8. doi: 10.1513/AnnalsATS.201512-825LE. [PubMed]

Handy JR, Costas K, Nisco S, Schaerf R, Vallières E, et al. Editorial: Regarding American College of Surgeons Commission on Cancer Non-Small Cell Lung Cancer Quality of Care Measure 10RLN. Ann Thorac Surg. 2016 Oct;102(4):1040-1. doi: 10.1016/j.athoracsur.2016.06.020. [PubMed]

Huang R, Wei Y, Hung RJ, Liu G, Su L, Zhang R, Zong X, Zhang ZF, Morgenstern H, Brüske I, Heinrich J, Hong YC, Kim JH, Cote M, Wenzlaff A, Schwartz AG, Stucker I, Mclaughlin J, Marcus MW, Davies MP, Liloglou T, Field JK, Matsuo K, Barnett M, Thornquist M, Goodman G, et al. Associated Links Among Smoking, Chronic Obstructive Pulmonary Disease, and Small Cell Lung Cancer: A Pooled Analysis in the International Lung Cancer Consortium. EBioMedicine. 2015 Nov;2(11):1677-85. [eCollection 2015 Nov] [PubMed]

Johnson CS, Louie BE, Wille A, Dunst CM, Worrell SG, DeMeester SR, Reynolds J, Dixon J, Lipham JC, Lada M, Peters JH, Watson TJ, Farivar AS, Aye RW. The Durability Of Endoscopic Therapy For Treatment Of Barrett’s Metaplasia, Dysplasia And Mucosal Cancer After Nissen Fundoplication. J Gastrointest Surg. 2015 May;19(5):799-805. doi: 10.1007/s11605-015-2783-6. [Epub 2015 Mar 5] [PubMed]

Kachuri L, Amos CI, McKay JD, Johansson M, Vineis P, Bueno-de-Mesquita HB, Boutron-Ruault MC, Johansson M, Quirós JR, Sieri S, Travis RC, Weiderpass E, Le Marchand L, Henderson BE, Wilkens L, Goodman G, et al. Fine-mapping of chromosome 5p15.33 based on a targeted deep sequencing and high density genotyping identifies novel lung cancer susceptibility loci. J Carcinogenesis. 2016 Jan;37(1):96-105. doi: 10.1093/carcin/bgv165. [Epub 2015 Nov 20] [PubMed]

Kachuri L, Amos CI, McKay JD, Johansson M, Vineis P, Bueno-de-Mesquita HB, Boutron-Ruault MC, Johansson M, Quirós JR, Sieri S, Travis RC, Weiderpass E, Le Marchand L, Henderson BE, Wilkens L, Louie BE and Vallières E. Esophagectomy for Primary and Secondary Motility Disorders. In: Sugarbaker D, ed. Adult Chest Surgery, 2nd Edition. New York, NY: McGraw-Hill; 2015. 292-298.

Kanodra NM, Rayburn JR, Wilshire CL, Gilbert CR, Weerasinghe RK, Craig E, Gorden JA. Intensive care unit procedure utilization at the end of life among patients with cancer: a community hospital network experience. The American Thoracic Society. Washington DC; May 22, 2017.

Kidane B, Peel JK, Seely A, Malthaner RA, Finley C, Grondin S, Louie BE, Srinathan S, Darling GE.  National Practice Variation in Pneumonectomy Perioperative Care: Results from a Survey of the Canadian Association of Thoracic Surgeons.  In press:  Interactive Cardiovascular and Thoracic Surgery (2017)   doi.org/10.1093/icvts/ivx252 [Oxford Academic]

Kim D-W, Tiseo M, Ahn M-J, Reckamp RL, Hansen KH, Kim S-W, Huber RM, West H, et al. Brigatinib (BRG) in patients (pts) with crizotinib (CRZ)-refractory ALK+ non-small cell lung cancer (NSCLC): First report of efficacy and safety from a pivotal randomized phase (ph) 2 trial (ALTA). J Clin Oncol. 2016;34 (suppl; abstr 9007). [ASCOpubs]

Kim D-W, Tiseo M, Ahn M-J, Reckamp RL, Hansen KH, Kim S-W, Huber RM, West H, et al. Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial. J Clin Oncol. 2017 Aug 1;35(22):2490-2498. doi: 10.1200/JCO.2016.71.5904. [Epub 2017 May 5] [PubMed]

Levy G, Aye RW, Farivar AS, Louie BE. A Combined Nissen Plus Hill Repair Reduces Recurrences for Paraesophageal Hernia Compared to Laparoscopic Nissen Alone. J Gastrointest Surg. 2017 Jan;21(1):121-125. doi: 10.1007/s11605-016-3225-9. [Epub 2016 Aug 4] [PubMed]

Levy G, Cordes MA, Farivar AS, Aye RW, Louie BE.  Transversus Abdominis Plane Block Improves Perioperative Outcomes After Esophagectomy versus Thoracic Epidural. Ann Thorac Surg. 2018 Feb;105(2):406-412. doi: 10.1016/j.athoracsur.2017.08.046. [Epub 2017 Dec 2] [PubMed]

Lipham JC, Taiganides PA, Louie BE, et al. Safety analysis of first 1,000 patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease. Dis Esophagus. 2015 May-Jun;28(4):305-11. doi: 10.1111/dote.12199. [Epub 2014 Mar 11] [PubMed]

Liu SV, Aggarwal C, Brzezniak C, Doebele RC, Gerber DE, Gitlitz B, Horn L, Solomon BJ, Stinchcombe T, Villaruz LC, West H, et al. Phase 2 study or tarloxotinib bromide (TRLX) in patients (pts) with EGFR-mutant, T790M-negative NSCLC progression on an EGFR TKI. J Clin Oncol. 2016;34 (suppl; abstr TPS9100). [ASCOpubs]

Liu CY, Stucker I, Chen C, Goodman GE, et al. Genome-wide gene-asbestos exposure interaction association study identifies a common susceptibility variant on 22q13.31 associated with lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2015 Oct;24(10):1564-73. doi: 10.1158/1055-9965.EPI-15-0021. [Epub 2015 Jul 21] [PubMed]

Louie BE.  Invited Editorial Commentary:  Is Tissue the Issue? Journal of Thoracic and Cardiovascular Surgery. (2017) 153(6): 1598-1599. [JTCVS]

Louie BE.  Invited Editorial Commentary:  To resect or not to resect in T1 Esophageal Carcinoma. Journal of Thoracic and Cardiovascular Surgery. (2017) 153:1208. [JTCVS]

Louie BE, Schneider AM, Schembre DB, Aye RW. Impact of Prior Interventions on outcomes during per oral endoscopic myotomy. Surg Endosc. 2017 Apr;31(4):1841-1848. doi: 10.1007/s00464-016-5182-5. [Epub 2016 Aug 23] [PubMed]

Louie BE, Wilson JL, Kim S, Cerfolio RJ, Park BJ, Farivar AS, Vallières E, Aye RW, et al. Comparison of Video-Assisted Thoracoscopic Surgery and Robotic Approaches for Clinical Stage I and Stage II Non-Small Cell Lung Cancer Using The Society of Thoracic Surgeons Database.  Ann Thorac Surg. 2016 Sep;102(3):917-924. doi: 10.1016/j.athoracsur.2016.03.032. [Epub 2016 May 19] [PubMed]

Louie BE, Yao X, Antonicelli A, Vallières E, Gu Z, Detterbeck F, Huang J, Shang Y, Aye RW, Farivar AS, Fang W. Partial Thymectomy Results In Similar Outcomes To Total Thymectomy In Masaoka-Koga Stages I And II Thymoma. Submitted to Journal of Thoracic and Cardiovascular Surgery. (2017) [PubMed]

Merzlikin OV, Louie BE, Farivar AS, Shultz D, Aye RW. Repair of Symptomatic Paraesophageal Hernias in Elderly (>70 Years) Patients Results in Sustained Quality of Life at 5 or more years. Surg Endosc. 2017 Oct;31(10):3979-3984. doi: 10.1007/s00464-017-5432-1. [Epub 2017 Mar 31] [PubMed]

McClune JR, Wilshire CL, Gorden JA, Louie BE, Farviar AS, Stefanski MJ, Vallieres E, Aye RW, Gilbert CR. Safety and Efficacy of Intrapleural Tissue Plasminogen Activator and DNase during Extended Use in Complicated Pleural Space Infections. Can Respir J. 2016;2016:9796768. doi: 10.1155/2016/9796768. [Epub 2016 Jun 30] [PubMed]

McKay JD, Hung RJ, Han Y, Zong X, Carreras-Torres R, Christiani DC, Caporaso NE, Johansson M, Xiao X, Li Y, Byun J, Dunning A, Pooley KA, Qian DC, Ji X, Liu G, Timofeeva MN, Bojesen SE, Wu X, Le Marchand L, Albanes D, Bickeböller H, Aldrich MC, Bush WS, Tardon A, Rennert G, Teare MD, Field JK, Kiemeney LA, Lazarus P, Haugen A, Lam S, Schabath MB, Andrew AS, Shen H, Hong YC, Yuan JM, Bertazzi PA, Pesatori AC, Ye Y, Diao N, Su L, Zhang R, Brhane Y, Leighl N, Johansen JS, Mellemgaard A, Saliba W, Haiman CA, Wilkens LR, Fernandez-Somoano A, Fernandez-Tardon G, van der Heijden HFM, Kim JH, Dai J, Hu Z, Davies MPA, Marcus MW, Brunnström H, Manjer J, Melander O, Muller DC, Overvad K, Trichopoulou A, Tumino R, Doherty JA, Barnett MP, Chen C, Goodman GE, et al.  Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes.  Nat Genet. 2017 Jul;49(7):1126-1132. doi: 10.1038/ng.3892. [Epub 2017 Jun 12] [PubMed]

Modin HE, Fathi JT, Gilbert CR, Wilshire CL, Wilson AK, Aye RW, Farivar AS, Louie BE, Vallières E, Gorden JA. Pack-Year Cigarette Smoking History for Determination of Lung Cancer Screening Eligibility. Comparison of the Electronic Medical Record versus a Shared Decision-making Conversation. Ann Am Thorac Soc. 2017 Aug;14(8):1320-1325. doi: 10.1513/AnnalsATS.201612-984OC. [PubMed]

Molena D, Boys JA, Blackmon SH, Dickinson KJ, Dunst CM, Hofstetter WL, Lada MJ, Louie BE, et al. Esophagectomy Following Endoscopic Resection of Submucosal Esophageal Adenocarcinoma: A Highly Curative Procedure Even With Nodal Metastases. J Gastrointest Surg. 2017 Jan;21(1):62-67. doi: 10.1007/s11605-016-3210-3. [Epub 2016 Aug 25] [PubMed]

Ost, D, Ernst A, Lei X, Kovitz K, Benzaquen S, Diaz-Mendoza J, Greenhill S, Toth J, Feller-Kopman D, Puchalski J, Baram D, Karunakara R, Jimenez C, Filner J, Morice R, Eapen G, Michaud G, Estrada-Y-Martin R, Rafeq S, Grosu H, Ray, C, Gilbert C, Yarmus L, Simoff M. Diagnostic Yield and Complications of Bronchoscopy for Peripheral Lung Lesions: Results of the AQuIRE Registry. Am J Respir Crit Care Med. 2016 Jan 1;193(1):68-77. doi: 10.1164/rccm.201507-1332OC. [PubMed]

Phillips M, Bauer TL, Cataneo RN, Lebauer C, Mundada M, Pass HI, Rmakrishna N, Rom WN, Vallières E. Blinded Validation of Breath Biomarkers of Lung Cancer, a Potential Ancillary to Chest CT Screening. PLoS ONE. 2015 Dec 23;10(12):e0142484. doi: 10.1371/journal.pone.0142484 [eCollection 2015] [PubMed]

Pujol JL, De Pas T, Rittmayer A, Vallières E, Kubisa B, Levchenko E, Wiesemann S, Masters GA, Shen R, Tjulandin SA, Hofmann HS, Vanhoutte N, Salaun B, Debois M, Jarnjak S, De Souva Ales PM, Louahed J, Brichard VG, Lehmann FF. Safety and immunogenicity of the PRAME cancer immunotherapeutic in patients with resected non‐small cell lung cancer:  a phase I dose escalation study. J Thor Oncol. 2016 Dec;11(12):2208-2217. doi: 10.1016/j.jtho.2016.08.120. [Epub 2016 Aug 17] [PubMed]

Rayburn JR, Wilshire CL, Fuller CC, Gilbert CR, Louie BE, Aye RW, Farivar AS, Vallières E, Gorden JA. Institutional assessment of adherence to guideline care in lung cancer diagnosis and staging negative impact of inconsistencies. The American Thoracic Society. Washington DC; May 22, 2017. [ATSJournals]

Rayburn JR, Wilshire CL, Gilbert CR, Weerasinghe RK, Craig E, Gorden JA. Underutilization of end of life care plans and palliative care resources in lung cancer patients admitted to intensive care units. The American Thoracic Society. Washington DC; May 24, 2017. [ATSJournals]

Reed M, Gilbert C, Taylor M, Toth J. Endobronchial Valves for Challenging Air Leaks. Ann Thorac Surg. 2015 Oct;100(4):1181-6. doi: 10.1016/j.athoracsur.2015.04.104. [Epub 2015 Jul 26] [PubMed]

Rice S, Liu X, Miller B, Joshi M, Zhu J, Caruso C, Gilbert C, et al. Proteomic profiling of human plasma identifies apolipoprotein E (APOE) as being associated with smoking and a marker for squamous metaplasia of the lung. Proteomics. 2015 Sep;15(18):3267-77. doi: 10.1002/pmic.201500029. [Epub 2015 Jul 3] [PubMed]

Ruhaak LR, Stroble C, Dai J, Barnett M, Taguchi A, Goodman GE, et.al. Serum Glycans as Risk Markers for Non-Small Cell Lung Cancer. Cancer Prev Res (Phila). 2016 Apr;9(4):317-23. doi: 10.1158/1940-6207.CAPR-15-0033. [Epub 2016 Jan 26] [PubMed]

Schneider AM, Louie BE. Anatomy of the Reflux Barrier in Health, Disease and Reconstruction. In: Aye RW, Hunter J, eds. Fundoplication Surgery: A Clinical Guide to Optimizing Results. New York, NY: Springer; 2015. 1-17.

Schneider AM, Louie BE, Warren HF, Farivar AS, Schembre DB, Aye RW. Matched Comparison of Per Oral Endoscopic Myotomy to Laparoscopic Heller Myotomy for the Treatment of Achalasia. J Gastrointest Surg. 2016 Nov;20(11):1789-1796. [Epub 2016 Aug 11] [PubMed]

Shaw AT, Gandhi L, Gadgeel S, Riely GJ, Cetnar J, West H, et al. Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicenter, phase 2 trial. Lancet Oncol. 2016 Feb;17(2):234-242. doi: 10.1016/S1470-2045(15)00488-X. [Epub 2015 Dec 19] [PubMed]

Toth J, Podany A, Reed M, Rocourt D, Gilbert C, et al. Endobronchial Occlusion with One-Way Endobronchial Valves: A Novel Technique for Persistent Air Leaks in Children. J Pediatr Surg. 2015 Jan;50(1):82-5. doi: 10.1016/j.jpedsurg.2014.10.007. [Epub 2014 Oct 23] [PubMed]

Warren HF, Brown LM, Mihura M, Farivar AS, Aye RW, Louie BE.  Factors Influencing the Outcome of Magnetic Sphincter Augmentation for Chronic Gastroesophageal Reflux Disease. Surg Endosc. 2018 Jan;32(1):405-412. doi: 10.1007/s00464-017-5696-5. [Epub 2017 Jun 29] [PubMed]

Warren HF, Louie BE, Farivar AS, Wilshire C, Aye RW. Manometric Changes to the Lower Esophageal Sphincter After Magnetic Sphincter Augmentation in Patients with Chronic Gastroesophageal Reflux Disease. Ann Surg. 2017 Jul;266(1):99-104. doi: 10.1097/SLA.0000000000001935 [PubMed]

Warren HF, Reynolds JL, Lipham JC, Zehetner J, Bildzukewicz NA, Taiganides PA, Mickley J, Aye RW, Farivar AS, Louie BE. Multi Institutional Outcomes Using Magnetic Sphincter Augmentation Versus Nissen Fundoplication for Chronic Gastroesophageal Reflux Disease. Surg Endosc. 2016 Aug;30(8):3289-96. doi: 10.1007/s00464-015-4659-y. [Epub 2015 Nov 5] [PubMed]

Weerasinghe RK, Craig E, Rayburn JR, Wilshire CL, Gilbert CR, Gorden JA. Variability in intensive care unit utilization at the end of life in patients with a diagnosis of cancer: a large multi-state hospital network experience. The American Thoracic Society. Washington DC; May 23, 2017. [ATSJournals]

West H. Highlights of recent studies of metastatic non-small cell lung cancer. JAMA Oncol. 2016 Oct 6. doi: 10.1001/jamaoncol.2016.3676. [Epub ahead of print] [PubMed]

West H. Young patients with lung cancer – an understudied population. JAMA Oncol. 2016 Mar;2(3):321. doi: 10.1001/jamaoncol.2015.4479. [PubMed]

West H, Nishio M, Dols MC, Saito H, Howland M, Hoang T, Deng T, Sandler A, Socinski MA. Impower132:a phase III clinical trial of 1L atezolizumab plus platinum-based chemotherapy in chemo-naïve advanced non-squamous NSCLC. J Clin Oncol 34, 2017 (suppl; abstr TPS9101).   [ASCOpubs]

Wikoff WR, Hanash S, DeFelice B, Miyamoto S, Barnett M, Zhao Y, Goodman G, et al. Diacetylspermine Is a Novel Prediagnostic Serum Biomarker for Non-Small-Cell Lung Cancer and Has Additive Performance With Pro-Surfactant Protein B. J Clin Oncol. 2015 Nov 20;33(33):3880-6. doi: 10.1200/JCO.2015.61.7779. [Epub 2015 Aug 17] [PubMed]

Wilshire CL, Aye RW, Farivar AS, Louie BE, Gorden J. Safety and Efficacy of Fibrinolytic Therapy in Restoring Function of an Obstructed Tunneled Pleural Catheter. Ann Am Thorac Soc. 2015;12(9):1317-22. doi: 10.1513/AnnalsATS.201503-182OC. [PubMed]

Wilshire CL, Fuller CC, Gilbert CR, Louie BE, Aye RW, Farivar AS, Vallières E, Gorden JA.  Imaging in Pleural Infections:  The Radiation Adds Up; European Respiratory Society International Congress 2017 Milan, Italy.

Wilshire CL, Louie BE, Horton MP, Castiglioni M, Aye RW, Farivar AS, West HL, Gorden J, Vallières E. Comparison of outcomes for patients with lepidic pulmonary adenocarcinoma defined by 2 staging systems: A North American experience. J Thorac Cardiovasc Surg. 2016 Jun;151(6):1561-8. doi: 10.1016/j.jtcvs.2016.01.029. [Epub 2016 Jan 22] [PubMed]

Wilshire CL, Louie BE, Manning KA, Horton MP, Castiglioni M, Gorden J,  Aye RW, Farivar AS, Vallières E. Radiologic Evaluation of Small Lepidic Adenocarcinomas to Guide Decision Making in Surgical Resection. Ann Thorac Surg. 2015 Sep;100(3):979-88. doi: 10.1016/j.athoracsur.2015.04.030. [Epub 2015 Jul 29] [PubMed]

Wilshire CL, Louie BE, Shultz D, Jutric Z, Farivar AS, Aye RW. Clinical Outcomes Of Reoperation For Failed Antireflux Surgery. Ann Thorac Surg. 2016 Apr;101(4):1290-6. doi: 10.1016/j.athoracsur.2015.10.027. [Epub 2015 Dec 17] [PubMed]

Wilshire CL, Vallières E, Shultz D, Aye RW, Farivar AS, Louie BE. Robotic resection of 3 cm and larger thymomas is associated with low perioperative morbidity and mortality. Innovations (Phila). 2016 Sep/Oct;11(5):321-326. [PubMed]

Worrell SG, Boys JA, Vallone JG, Chandrasoma P, Oh DS, Hagen JA, Johnson C, Lada MJ, Dunst CM, Louie BE, et al. Inter-Observer Variability in the Interpretation of Endoscopic Mucosal Resection Specimens. J Gastrointest Surg. 2016 Jan;20(1):140-4; discussion 144-5. doi: 10.1007/s11605-015-3009-7. [Epub 2015 Oct 26] [PubMed]

Yu HA, Spira AI, Horn L, Weiss J, West H, et al. Antitumor activity of ASP8273 300 mg in subjects with EGFR mutation-positive non-small cell lung cancer. Interim results from an ongoing phase 1 study. J Clin Oncol. 2016;34 (suppl; abstr 9050). [ASCOpubs]

Yu HA, Spira AI, Horn L, Weiss J, West H, et al. A Phase I, Dose Escalation Study of Oral ASP8273 in Patients with Non-small Cell Lung Cancers with Epidermal Growth Factor Receptor Mutations. Clin Cancer Res. 2017 Dec 15;23(24):7467-7473. doi: 10.1158/1078-0432.CCR-17-1447. [Epub 2017 Sep 27] [PubMed]

Zhou F, Wang Y, Liu H, Ready N, Han Y, Hung RJ, Brhane Y, McLaughlin J, Brennan P, Bickeböller H, Rosenberger A, Houlston RS, Caporaso N, Landi MT, Brüske I, Risch A, Ye Y, Wu X, Christiani DC, Goodman G, Chen C. Transdisciplinary Research in Cancer of the Lung (TRICL) Research Team., Amos CI, Qingyi W. Susceptibility loci of CNOT6 in the general mRNA degradation pathway and lung cancer risk – a re-analysis of eight GWASs. Mol Carcinog. 2017 Apr;56(4):1227-1238. doi: 10.1002/mc.22585. [Epub 2016 Nov 2]. [PubMed]

Other

Christen WG, Glynn RJ, Gaziano JM, Darke AK, Crowley JJ, Goodman PJ, Lippman SM, Lad TE, Bearden JD, Goodman GE, et al. Age-Related Cataract in Men in the Selenium and Vitamin E Cancer Prevention Trial Eye Endpoints Study: A Randomized Clinical Trial. JAMA Ophthalmol. 2015 Jan;133(1):17-24. doi: 10.1001/jamaophthalmol.2014.3478. [PubMed]

Crickman R. Project Planning and the Work of Translation. In: White KM, Dudley-Brown S, Terhaar MF, eds. Translation of Evidence into Nursing and Health Care, 2nd ed. New York, NY: Springer. 2016.

Crickman R. Systematic Review of Control Measures to Reduce Hazardous Drug Exposure for Health Care Workers. J Nurs Care Qual. 2016 Apr-Jun;31(2):183-90. doi: 10.1097/NCQ.0000000000000155. [PubMed]

Crickman, R., Finnell, D. S. (2017). Chemotherapy safe handling: Limiting nursing exposure with a hazardous drug control program. Clinical Journal of Oncology Nursing21(1), 73-78. doi: 10.1188/17.CJON.73-78 [PubMed]

Davis JL, Mathes E, Berry AB. FNA diagnosis of giant cell fibroblastoma: a case report of an unusual pediatric soft tissue tumor. Diagn Cytopathol. 2015 Apr;43(4):325-8. doi: 10.1002/dc.23201. [Epub 2014 Aug 4] [PubMed]

Gupta A, West H. Mucositis (or stomatitis). JAMA Oncol. 2016 Oct 1;2(10):1379. doi: 10.1001/jamaoncol.2016.2103. [PubMed]

Subbiah V, West HL. Bone complications in patients with cancer. JAMA Oncol. 2016 Mar 24. doi: 10.1001/jamaoncol.2015.3495. [Epub ahead of print] [PubMed]

Subbiah V, West HL. Jaundice (hyperbilirubinemia) in cancer. JAMA Oncol. 2016 Aug 1;2(8):1103. doi:10.1001/jamaoncol.2016.1236. [PubMed]

Thompson N, Christian A. Oral Chemotherapy: Not just an ordinary pill. Am Nurse Today. 2016;11(9);16-22. [AMT]

West H. Balancing benefit, risk, and time to new cancer therapies. JAMA Oncol. 2016 Jan;2(1):122. doi: 10.1001/jamaoncol.2015.4126. [PubMed]

West H, Jin J. Lymph nodes and lymphadenopathy. JAMA Oncol. 2016 Jul 1;2(7):971. doi: 10.1001/jamaoncol.2015.3509. [PubMed]

West H, Jin J. Portacaths. JAMA Oncol. 2016 Jan;2(1):152. doi: 10.1001/jamaoncol.2015.3488. [PubMed]